CAROLINE GAWTHROP: Open Payments
NPI 1629705736 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 24 payments from 9 companies in 2025. Trend: 2023 $137 · 2024 $56 · 2025 $783
Food & beverage: $689Education: $95
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $301 |
| GENZYME CORPORATION | 6 | $237 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| CSL Behring | 2 | $50 |
| Genentech USA, Inc. | 1 | $34 |
| Cycle Pharmaceuticals Inc | 1 | $29 |
| Optinose US, Inc. | 1 | $22 |
| Grifols USA, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: DUPIXENT, Rhapsido, Hizentra, Xolair, Sajazir, Xhance, Xembify, TEZSPIRE.
Industry payments across TN — which companies pay providers there.
